Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 9473-9474 [2016-03989]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
Additional members may be
appointed at the discretion of the WTC
Program Administrator.
A STAC member’s term appointment
may last 3 years. If a vacancy occurs, the
WTC Program Administrator may
appoint a new member who fulfills the
same membership category as the
predecessor. STAC members may be
appointed to successive terms. The
frequency of committee meetings shall
be determined by the WTC Program
Administrator based on program needs.
Meetings may occur up to four times a
year. Members are paid the Special
Government Employee rate of $250 per
day, and travel costs and per diem are
included and based on the Federal
Travel Regulations.
Any interested person or organization
may self-nominate or nominate one or
more qualified persons for membership.
Nominations must include the
following information:
• The nominee’s contact information
and current occupation or position;
• The nominee’s resume or
curriculum vitae, including prior or
current membership on other National
Institute for Occupational Safety and
Health (NIOSH), CDC, or HHS advisory
committees or other relevant
organizations, associations, and
committees;
• The category of membership
(environmental medicine or
environmental health specialist,
occupational physician, pulmonary
physician, representative of WTC
responders, or certified-eligible WTC
survivor representative) that the
candidate is qualified to represent;
• A summary of the background,
experience, and qualifications that
demonstrates the nominee’s suitability
for the nominated membership category;
• Articles or other documents the
nominee has authored that indicate the
nominee’s knowledge and experience in
relevant subject categories; and
• A statement that the nominee is
aware of the nomination, is willing to
regularly attend and participate in
STAC meetings, and has no known
conflicts of interest that would preclude
membership on the Committee.
STAC members will be selected upon
the basis of their relevant experience
and competence in their respective
categorical fields. The information
received through this nomination
process, in addition to other relevant
sources of information, will assist the
WTC Program Administrator in
appointing members to serve on the
STAC. In selecting members, the WTC
Program Administrator will consider
individuals nominated in response to
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
this Federal Register notice, as well as
other qualified individuals.
The CDC is committed to bringing
greater diversity of thought, perspective,
and experience to its advisory
committees. Nominees from all races,
genders, ages, and persons living with
disabilities are encouraged to apply.
Nominees must be U.S. citizens.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Report,’’ OGE
Form 450. This form is used by CDC to
determine whether there is a financial
conflict between that person’s private
interests and activities and their public
responsibilities as a Special Government
Employee as well as any appearance of
a loss of impartiality, as defined by
Federal regulation. The form may be
viewed and downloaded at https://
www.oge.gov/Forms-Library/OGE-Form450_Confidential-Financial-DisclosureReport/. This form should not be
submitted as part of a nomination.
Nominations must be submitted
(postmarked or electronically received)
by March 31, 2016.
Submissions must be electronic or by
mail. Submissions should reference
docket 229–D. Electronic submissions:
You may electronically submit
nominations, including attachments, to
nioshdocket@cdc.gov. Attachments in
Microsoft Word are preferred. Regular,
Express, or Overnight Mail: Written
nominations may be submitted (one
original and two copies) to the following
address only: NIOSH Docket 229–D,
c/o Mia Wallace, Committee
Management Specialist, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE., MS:
E–20, Atlanta, Georgia 30333.
Telephone and facsimile submissions
cannot be accepted.
DATES:
Paul
Middendorf, Acting Deputy Associate
Director for Science, 1600 Clifton Rd.
NE., MS: E–20, Atlanta, GA 30333;
telephone (404)498–2500 (this is not a
toll-free number); email
pmiddendorf@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
9473
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03933 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOA) IP16–003, Research on the
Epidemiology, Prevention, Vaccine
Effectiveness and Treatment of
Influenza and Other Respiratory Viruses
in South Africa and IP16–004,
Enhanced Surveillance for New Vaccine
Preventable Diseases.
Time and Date: 10:00 a.m.–5:00 p.m.,
EDT, March 30–31, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research on the Epidemiology,
Prevention, Vaccine Effectiveness and
Treatment of Influenza and Other
Respiratory Viruses in South Africa’’,
IP16–003 and ‘‘Enhanced Surveillance
for New Vaccine Preventable Diseases’’,
IP16–004.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\25FEN1.SGM
25FEN1
9474
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03989 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Agency Forms Undergoing Paperwork
Reduction Act Review
Proposed Project
Workplace Health In America—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
Background and Brief Description
CDC has developed the Workplace
Health in America survey program to
describe the current state of U.S.
workplace health promotion and
protection programs and practices in
employers of all sizes, industries and
regions. To date, there has not been a
systematic and ongoing effort to
document the evidenced-based and best
practice strategies and interventions that
comprise a comprehensive workplace
health program from a nationally
representative sample of employers.
National worksite health promotion
experts, employers, and content experts
from the CDC advised on the survey
content. Items from existing, validated
surveys were used whenever possible.
The survey contains yes/no, multiple
choice and a small number of openended items.
The Workplace Health in America
survey is designed to collect
information about: Basic organizational
characteristics; employer-sponsored
health insurance; health risk
assessments; staffing and other
resources devoted to employee health
and safety programming; incentives;
work-life policies and benefits;
availability of health screenings and
disease management programs;
occupational safety and health
programs. The survey items also cover
the presence of evidence-based and
other health promotion programs,
[30-Day–16–16FG]
policies and supports related to physical
activity; nutrition; weight; tobacco;
excess alcohol use and drug abuse;
lactation and prenatal support;
musculoskeletal disorders, arthritis and
back pain; stress; and sleep.
The information that is collected is
intended to build an infrastructure
supporting ongoing surveillance to
evaluate national workplace health
priorities (e.g., Healthy People), monitor
trends, and address emerging issues;
provide free and accessible
benchmarking data for employers and
other stakeholders in workplace health
promotion and protection; provide a
better understanding of employer
practices to inform the development of
tools and resources to support the
design, implementation, and evaluation
of employer-based workplace health
programs; and advance workplace
health promotion and protection
research.
To achieve these aims, CDC has
developed an infrastructure for this
initial effort that can be expanded for
future iterations of data collection. CDC
has designed a process to select a
nationally representative sample of
worksites representing employers in all
size categories, industry sectors, and
CDC regions. The data collection
platform was developed to collect
information primarily by online survey
or telephone assisted interview, and can
be easily modified to accommodate
additional survey modules. CDC has
also created a dissemination plan to
ensure the data and results can be used
by employers and other stakeholders
beyond the research community.
Planned dissemination products include
webinars to employer groups, an online
dashboard for employers to benchmark
their programs against other employers
with comparable characteristics, and
brief reports tailored to employers of
different sizes.
OMB approval is requested for two
years. CDC estimates that a total 8,085
employers will complete the Workplace
Health in America survey. Participation
is voluntary and there are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 5,616.
mstockstill on DSK4VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
Wellness/HR representative ...........................
Screening and Recruiting call ........................
Workplace Health in America Survey ............
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Number of
respondents
11,684
4,043
E:\FR\FM\25FEN1.SGM
25FEN1
Number of
responses per
respondent
1
1
Average
burden per
response
(in hours)
15/60
40/60
]]>Agencies
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Pages 9473-9474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03989]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcements (FOA)
IP16-003, Research on the Epidemiology, Prevention, Vaccine
Effectiveness and Treatment of Influenza and Other Respiratory Viruses
in South Africa and IP16-004, Enhanced Surveillance for New Vaccine
Preventable Diseases.
Time and Date: 10:00 a.m.-5:00 p.m., EDT, March 30-31, 2016
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Research on the Epidemiology, Prevention, Vaccine Effectiveness
and Treatment of Influenza and Other Respiratory Viruses in South
Africa'', IP16-003 and ``Enhanced Surveillance for New Vaccine
Preventable Diseases'', IP16-004.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and
[[Page 9474]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-03989 Filed 2-24-16; 8:45 am]
BILLING CODE 4163-18-P
